Beta Bionics, Inc. (BBNX) Total Liabilities (2023 - 2026)

Beta Bionics (BBNX) has 4 years of Total Liabilities data on file, last reported at $33.2 million in Q1 2026.

• Quarterly Total Liabilities rose 36.67% year-over-year to $33.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $33.2 million (up 36.67% YoY) and the FY2025 annual result came in at $41.1 million, down 44.14% from the prior year.
• Total Liabilities eased to $33.2 million in Q1 2026 per BBNX's latest filing, from $41.1 million in the prior quarter.
• The five-year high for Total Liabilities was $228.8 million in Q3 2024, with the low at $24.3 million in Q1 2025.
• Average Total Liabilities over 4 years is $95.2 million, with a median of $46.3 million recorded in 2023.
• Year-over-year, Total Liabilities soared 43.16% in 2024 and tumbled 88.68% in 2025.
• Beta Bionics' Total Liabilities stood at $51.4 million in 2023, then soared by 43.16% to $73.6 million in 2024, then plunged by 44.14% to $41.1 million in 2025, then retreated by 19.35% to $33.2 million in 2026.
• Business Quant data shows BBNX's Total Liabilities at $33.2 million in Q1 2026, $41.1 million in Q4 2025, and $35.3 million in Q3 2025.